Also known as Nimotop
Nimodipine (marketed by Bayer as Nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm; this is now the main use of nimodipine.Source: Wikipedia
Estimated Total Cost: $672.47 for an average of 28 days supply
Patients are most commonly prescribed nimodipine to treat blastomycosis, rabies, west nile virus, and pick disease.